Rapid Regression of Neurological Symptoms in Patients With Metastasised ALK+ Lung Cancer Who Are Treated With Lorlatinib: A Report of Two Cases

BMJ Case Reports - United Kingdom
doi 10.1136/bcr-2018-227299
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

BMJ


Related search